HIV-I protease: Maturation, enzyme specificity, and drug resistance
- 1 January 2000
- book chapter
- Published by Elsevier
- Vol. 49, 111-146
- https://doi.org/10.1016/s1054-3589(00)49025-3
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins 1 1Edited by J. KarnJournal of Molecular Biology, 1998
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinasesBiochemical and Biophysical Research Communications, 1990
- Substitutions at the P2′ site of gag p17–p24 affect cleavage efficiency by HIV-1 proteaseBiochemical and Biophysical Research Communications, 1990
- Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activityBiochemical and Biophysical Research Communications, 1989
- Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virys proteaseGene Analysis Techniques, 1988
- HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsBiochemical and Biophysical Research Communications, 1988